Web News Insider
-
Enoki Mushrooms and Cancer: What Mouse Studies and Nagano Data Really Show
Animal trials used purified extracts to boost immunity in mice, while a 1989 Japanese study linked lower cancer rates in farmers to…
-
Nationwide Lifts Fixed Rate Cash ISAs to 5.00% AER, but Better Rates Exist
With Nationwide boosting rates to 5%, savers can now maximize emergency funds via tax-free ISAs that outpace inflation while avoiding the penalties…
-
What Clinical Trials Really Show About Tigilanol Tiglate from the Blushwood Berry
A viral social media post revived interest in the rainforest drug, but current human trials reveal targeted local results rather than a…
-
MK615 Apricot Extract: Lab Promise vs. Limited Human Trial Data
While viral clips claim MK615 kills 95% of cancer cells, a small Phase I trial showed only disease stabilization, not tumor shrinkage,…
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
Analyze the practical mechanics of aggressive credit card debt paydown strategies and how issuers profit from the revolving balances you carry.
-
Epigenetic Clocks: Measuring Biological Age and Predicting Mortality
LONDON, July 8 — The biological clock may be more than a metaphor. For over a decade, researchers have been building tools…
-
Suze Orman Says Parents Should Not Fund Trump Accounts Until Their Own Finances Are Solid
The financial advisor argues that rising healthcare costs require a larger safety net, urging households to prioritize an eight-month cash buffer before…
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
A phase 1 trial of an engineered CD40 antibody published in Cancer Cell found tumor shrinkage in half of 12 patients, with…
-
How Frozen Tax Thresholds Erode the Purchasing Power of Social Security’s 2027 COLA
Unindexed provisional income limits from 1983 mean a 3.6% benefit increase pushes more retirement income into taxable territory, reducing the real value…
-
Personalized mRNA Vaccine Cuts Melanoma Recurrence Risk 42% in Late-Stage Trial
Discover how custom mRNA cancer vaccines train the immune system against tumor neoantigens to prevent melanoma recurrence compared to standard adjuvant therapy.
-
How Dynasty Trusts Preserve Wealth for a Century Using GST Exemptions
A $15 million trust funded in 2026 can avoid federal transfer taxes until 2126 by allocating GST exemption and situs in a…
-
Understanding Individual Voluntary Arrangements: How They Work and Affect Credit
An exploration of how Individual Voluntary Arrangements operate as a debt relief tool, their history, and their lasting impact on consumer credit.
-
State Tax Policies on IRA Withdrawals Shape Retirement Savings for Seniors
Differences in state-level tax treatments on IRA withdrawals can significantly affect a retiree’s long-term financial stability, as seen in Arizona and Nevada.
-
Carrying High Credit Card Debt While Using HYSA Costs You Money
The math is brutal, and it doesn’t care about your feelings. Carrying a credit card balance above 20 percent APR while also…
-
Sugary Drinks Linked to Higher Teen Anxiety and Depression Risk in Australian Study
A three‑year study of 6,500 Australian adolescents shows daily sugary‑drink intake increases the odds of meeting screening thresholds for depression and anxiety,…
-
How Liquid Biopsy Is Transforming Cancer Monitoring and Early Detection Strategies
Non-invasive blood tests are moving beyond niche use to become vital tools for tracking treatment response, detecting recurrence, and screening for cancer.
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
The 2026 AACR Cancer Progress Report highlights a rise in survival rates and the emergence of innovative drug classes like PROTACs and…
-
How Virginia Medicaid Can Bill an Estate $38,000 for Premiums Paid to a Health Plan
Understand the legal mechanisms behind state estate recovery programs, managed care capitation payments, and how families face unexpected property claims.
-
Medicare Advantage Agents Earn Up to $725 per Enrollment While Original Medicare Pays Nothing
Federal caps allow agents to earn hundreds for Medicare Advantage sign-ups while paying nothing for Original Medicare recommendations.
-
Viatris Secures FDA Approval for RYZUMVI to Treat Presbyopia in Adults
Viatris wins FDA approval for RYZUMVI to treat presbyopia, adding a new option for aging eyes while seeking a U.S. commercial partner.
-
The Growing Financial and Regulatory Realities of Concierge Medicine Models
As concierge practices surge in popularity, patients and providers must navigate complex Medicare rules regarding membership fees and covered services.
-
European Regulators Back Breakthrough Pancreatic Cancer Drug Rasonque
The EMA has recommended approval for daraxonrasib, a daily pill that doubles survival rates for patients with metastatic pancreatic adenocarcinoma.
-
How a Hidden Fat-Sensing Protein Could Unlock Immunotherapy for Deadly Colorectal Cancers
A new study reveals how tweaking a single molecular switch in immune cells could turn ‘untreatable’ tumors into immunotherapy responders—without headlines.
-
How Texas’ $6B CPRIT Outpaces NIH in Speeding Cancer Breakthroughs
The state’s aggressive funding model recruits top researchers and accelerates treatments—while federal grants face slower bureaucratic hurdles.
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992